CVE-2026-24217 — HIGH (8.8)

Q: How severe is CVE-2026-24217?

CVE-2026-24217 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2026-24217?

Check the references section above for vendor advisories and patch information. Affected products include: Nvidia Bionemo Framework, Linux Linux Kernel.

Vulnerability Description

NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

CVSS Score

8.8

HIGH

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

UNCHANGED

Confidentiality

HIGH

Integrity

HIGH

Availability

HIGH

Affected Products

Vendor	Product	Versions
Nvidia	Bionemo Framework	< 2026-04-03
Linux	Linux Kernel	-

Related Weaknesses (CWE)

CWE-29

References

https://nvd.nist.gov/vuln/detail/CVE-2026-24217US Government Resource
https://nvidia.custhelp.com/app/answers/detail/a_id/5831Vendor Advisory
https://www.cve.org/CVERecord?id=CVE-2026-24217Third Party Advisory

FAQ

What is CVE-2026-24217?

CVE-2026-24217 is a vulnerability with a CVSS score of 8.8 (HIGH). NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, d...

How severe is CVE-2026-24217?

CVE-2026-24217 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-24217?

Check the references section above for vendor advisories and patch information. Affected products include: Nvidia Bionemo Framework, Linux Linux Kernel.